Gaush Meditech Innovates Dry Eye Diagnostics

Gaush Meditech Ltd. (HK:2407) has released an update.

Gaush Meditech Ltd has announced that its subsidiary, Gaush Neotech, has received medical device registration certificates for two innovative diagnostic devices aimed at addressing the widespread issue of dry eye disease. These devices, Gaush iDea FOS and Gaush iDea Topo, promise fast, non-invasive, and accurate diagnostics for dry eye and corneal topography, potentially benefiting a rapidly growing number of patients with dry eye disease in China.

For further insights into HK:2407 stock, check out TipRanks’ Stock Analysis page.